Company Profile
Medy-Tox is a biopharmaceutical company in South Korea. It provides botulinum toxin products, including Neuronox, a lyophilized white power for injection that is used to treat foot deformities due to spasticity in pediatric cerebral palsy patients.
Its portfolio also includes INNOTOX, a colorless transparent liquid-filled injection that is used to temporarily improve moderate to severe glabellar wrinkles, and Coretox, a lyophilized white power for injection that is used to temporarily improve moderate to severe glabellar wrinkles Hyaluronic acid filler products comprising Neuramis and Potenfill that are tissue recovering biomaterials.
Additionally, it provides various medical devices, such as ComfortDual for tissue coagulation by using high-frequency current. Its portfolio also includes Neurajet Plus to assist injecting other pharmaceuticals, and Carewave for improving erectile dysfunction by using low-intensity shock wave generated from the electromagnetic method. It also exports its products to approximately 60 countries, including Japan, Brazil, and globally. Founded in 2000, Medy-Tox is headquartered in Cheongju, South Korea.